POSTMARKING SURVEILLANCE OF ALPRAZOLAM POPULATION PHARMACOKINETICS

被引：0
|
作者：
GRASELA, TH
DEVANE, CL
HILL, M
ANTAL, EJ
机构：
[1] SUNY BUFFALO,SCH PHARM,BUFFALO,NY 14260
[2] UNIV FLORIDA,COLL PHARM,GAINESVILLE,FL 32611
[3] UNIV FLORIDA,COLL MED,GAINESVILLE,FL 32611
[4] NATL JEWISH HOSP & RES CTR,DENVER,CO 80206
[5] UPJOHN CO,PHARMACOKINET PHARMACODYNAM UNIT,KALAMAZOO,MI 49001
来源：
PHARMACOTHERAPY | 1988年 / 8卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF ALPRAZOLAM
    ABERNETHY, DR
    GREENBLATT, DJ
    DIVOLL, M
    SHADER, RI
    JOURNAL OF CLINICAL PSYCHIATRY, 1983, 44 (08) : 45 - 47
  • [2] Effect of venlafaxine on the pharmacokinetics of alprazolam
    Amchin, J
    Zarycranski, W
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 410 - 410
  • [3] Effect of alosetron on the pharmacokinetics of alprazolam
    D'Souza, DL
    Levasseur, LM
    Nezamis, J
    Robbins, DK
    Simms, L
    Koch, KM
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (04): : 452 - 454
  • [4] Effect of venlafaxine on the pharmacokinetics of alprazolam
    Amchin, J
    Zarycranski, W
    Taylor, KP
    Albano, D
    Klockowski, PM
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (02) : 211 - 219
  • [5] CLINICAL PHARMACOKINETICS OF ALPRAZOLAM - THERAPEUTIC IMPLICATIONS
    GREENBLATT, DJ
    WRIGHT, CE
    CLINICAL PHARMACOKINETICS, 1993, 24 (06) : 453 - 471
  • [6] Lack of effect of sertraline on the pharmacokinetics of alprazolam
    Preskorn, SH
    Greenblatt, DJ
    Harvey, AT
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (05) : 585 - 586
  • [7] ALPRAZOLAM PHARMACOKINETICS IN ALCOHOLIC LIVER-DISEASE
    JUHL, RP
    VANTHIEL, DH
    DITTERT, LW
    SMITH, RB
    JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (2-3): : 113 - 119
  • [8] Pharmacokinetics of alprazolam in elderly patients with multiple diseases
    Mühlberg, W
    Platt, D
    Rieck, W
    Arnold, E
    PSYCHOPHARMAKOTHERAPIE, 2001, 8 (03): : 122 - 127
  • [9] Pharmacokinetics of alprazolam in elderly patients with multiple diseases
    Muhlberg, W
    Rieck, W
    Arnold, E
    Ott, G
    Lungershausen, E
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1997, 25 (01) : 91 - 100
  • [10] THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM
    ABERNETHY, DR
    GREENBLATT, DJ
    DIVOLL, M
    SMITH, RB
    SHADER, RI
    CLINICAL PHARMACOKINETICS, 1984, 9 (02) : 177 - 183
12345